Clinical Trial Update: Resuscitation With Albumin 5% in Dengue Haemorrhagic Fever [Phase 3]

View source ↗

Summary

Phase 3 trial investigating resuscitation with 5% albumin in dengue hemorrhagic fever; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Hemorrhagic Fever

Drugs mentioned

• Albumin 5% (Human serum albumin)

Snippet

Sponsor: Indonesia University | Conditions: Dengue Hemorrhagic | Phase 3 | Status: UNKNOWN